Return to homepagePandemic Pact

Phase 1 First-in-Human, Time Lagged, Randomised, Placebo Controlled, Double, Blind, Single Ascending Dose Study of CB-10 and CB-30 Antibody Cocktail in Healthy Adult Volunteers

  • Funded by National Medical Research Council Singapore
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Medical Research Council Singapore

  • Principal Investigator

    Shirin Kalimuddin

  • Research Location

    Singapore

  • Lead Research Institution

    SHHQ

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract